Goldman Sachs Group Inc Rockwell Medical, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 82,679 shares of RMTI stock, worth $150,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,679
Previous 18,143
355.71%
Holding current value
$150,475
Previous $72,000
133.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RMTI
# of Institutions
65Shares Held
9.28MCall Options Held
339KPut Options Held
43.3K-
Armistice Capital, LLC New York, NY3.58MShares$6.52 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$2.19 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$1.35 Million0.13% of portfolio
-
Marshall Wace, LLP London, X0509KShares$925,7860.0% of portfolio
-
Geode Capital Management, LLC Boston, MA307KShares$559,2750.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $19.4M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...